latest news in Mergers
Zoar Debuts on the New York Stock Exchange Following Landmark Healthcare Merger
New York, Wednesday, 18 November 2026.
Impact Biomedical completed its strategic combination with Zoar Limited, debuting on the public market today backed by Zoar Labs’ $77.7 million annual net income and accelerating pipeline commercialization.